Report error Found 164 Enz. Inhib. hit(s) with Target = 'Serine/threonine-protein kinase NLK'
Affinity DataKd: 1.20nMAssay Description:Binding affinity to human NLK incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7nMAssay Description:Inhibition of human NLK using myelin basic protein as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 ...More data for this Ligand-Target Pair
Affinity DataKd: 16nMAssay Description:Binding affinity to human NLK incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Affinity DataKd: 25nMAssay Description:Binding constant for full-length NLKMore data for this Ligand-Target Pair
Affinity DataKd: 25nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 25nMAssay Description:Binding constant for NLK kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 28nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 28nMAssay Description:Binding constant for full-length NLKMore data for this Ligand-Target Pair
Affinity DataKd: 28nMAssay Description:Binding affinity to biotinylated full length human NLK expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET ba...More data for this Ligand-Target Pair
Affinity DataKd: 29nMAssay Description:Binding affinity to biotinylated full length human NLK expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET ba...More data for this Ligand-Target Pair
Affinity DataKd: 35nMAssay Description:Binding constant for NLK kinase domainMore data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:Inhibition of human NLK preincubated with compound for 1 hrs followed by ATP/33P-ATP addition and measured after 2 hrs by radioactive filter-binding ...More data for this Ligand-Target Pair
Affinity DataIC50: 55.5nMAssay Description:Inhibition of human NLK using MBP as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
Affinity DataIC50: 77.8nMAssay Description:Inhibition of human NLK using MBP as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
Affinity DataKd: 160nMAssay Description:Binding affinity to NLKMore data for this Ligand-Target Pair
Affinity DataKd: 160nMAssay Description:Binding constant for full-length NLKMore data for this Ligand-Target Pair
Affinity DataKd: 160nMAssay Description:Binding constant for NLK kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 160nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 170nMAssay Description:Binding constant for NLK kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 170nMAssay Description:Binding affinity to NLKMore data for this Ligand-Target Pair
Affinity DataKd: 220nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 220nMAssay Description:Binding constant for full-length NLKMore data for this Ligand-Target Pair
Affinity DataKd: 220nMAssay Description:Binding constant for NLK kinase domainMore data for this Ligand-Target Pair
Affinity DataIC50: 250nMAssay Description:Inhibition of human NLK by radiometric PanQinase activity assayMore data for this Ligand-Target Pair
Affinity DataKd: 260nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 260nMAssay Description:Binding constant for NLK kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 260nMAssay Description:Binding constant for full-length NLKMore data for this Ligand-Target Pair
Affinity DataIC50: 336nMAssay Description:Inhibition of NLK (unknown origin)More data for this Ligand-Target Pair
Affinity DataKd: 350nMAssay Description:Binding affinity to biotinylated full length human NLK expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET ba...More data for this Ligand-Target Pair
Affinity DataKd: 410nMAssay Description:Binding affinity to biotinylated full length human NLK expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET ba...More data for this Ligand-Target Pair
Affinity DataKd: 410nMAssay Description:Binding affinity to wild-type human full length NLK expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
Affinity DataKd: 480nMAssay Description:Binding constant for NLK kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 520nMAssay Description:Binding affinity to wild-type human full length NLK expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
Affinity DataKd: 520nMAssay Description:Binding affinity to biotinylated full length human NLK expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET ba...More data for this Ligand-Target Pair
Affinity DataKd: 640nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 640nMAssay Description:Binding affinity to NLKMore data for this Ligand-Target Pair
Affinity DataKd: 640nMAssay Description:Binding constant for full-length NLKMore data for this Ligand-Target Pair
Affinity DataKd: 640nMAssay Description:Binding constant for NLK kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 650nMAssay Description:Binding affinity to biotinylated full length human NLK expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET ba...More data for this Ligand-Target Pair
Affinity DataKd: 660nMAssay Description:Binding affinity to biotinylated full length human NLK expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET ba...More data for this Ligand-Target Pair
Affinity DataKd: 690nMAssay Description:Binding affinity to wild-type human full length NLK expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
Affinity DataKd: 700nMAssay Description:Binding affinity to biotinylated full length human NLK expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET ba...More data for this Ligand-Target Pair
Affinity DataKd: 770nMAssay Description:Binding affinity to NLKMore data for this Ligand-Target Pair
Affinity DataKd: 770nMAssay Description:Binding constant for NLK kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 790nMAssay Description:Binding affinity to biotinylated full length human NLK expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET ba...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human wild type NLK using RBER-GSK3(14-27) as substrate preincubated for 2 hrs followed by ATP addition and measured every 2 mins for 2...More data for this Ligand-Target Pair
Affinity DataKd: 1.00E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 1.00E+3nMAssay Description:Binding constant for NLK kinase domainMore data for this Ligand-Target Pair






























